Items where Author is "Eshghi, P."

Article

(2021) Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS. Blood Advances. pp. 2987-3001. ISSN 24739529 (ISSN)

(2020) Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study. Journal of Thrombosis and Haemostasis. pp. 2145-2154. ISSN 15387933 (ISSN)

(2018) Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients. Journal of Pharmacopuncture. pp. 76-81. ISSN 2093-6966

(2018) The comparison of efficacy of original brand deferoxamine with generic iranian made deferoxamine in urinary iron excretion in patients with thalassemia major. Iranian Journal of Blood and Cancer. pp. 108-111. ISSN 20084595 (ISSN)

(2017) Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: A longitudinal study. Pediatric Allergy and Immunology. pp. 478-484. ISSN 0905-6157

(2016) A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With Inhibitor. Clinical and Applied Thrombosis-Hemostasis. pp. 184-190. ISSN 1076-0296

(2016) Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven (TM)) and Activated Prothrombin Complex Concentrates (FEIBA (TM)) to Treat Hemophilia A Patients with Inhibitors in Iran. Iranian Journal of Pharmaceutical Research. pp. 669-677. ISSN 1735-0328

(2015) A Comparison Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Congenital Factor VII Deficiency. Clinical and Applied Thrombosis-Hemostasis. pp. 724-728. ISSN 1076-0296